Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

ELISA Development for the quantification of anti-drug IgG1 antibodies in animal sera

Description

Preclinical studies were performed for the development of a protein-based biopharmaceutical for the treatment of an auto-immune disease. The goal of the project is the development of an ELISA-based method for the detection and the quantification of potential anti-drug antibodies (ADA) in dog and rat sera.

Key data

Project status

completed, 11/2019 - 12/2020

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Third party

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.